Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06172933
Other study ID # 2023P003312
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2024
Est. completion date February 1, 2025

Study information

Verified date March 2024
Source Massachusetts General Hospital
Contact Christopher M Celano, MD
Phone 617-726-6485
Email ccelano@mgh.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized, controlled pilot trial (N=30) to examine the feasibility, acceptability, and preliminary efficacy of the Move with Meaning program, an 8- week, text message- and audio-based intervention to promote physical activity in midlife adults.


Description:

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the Move with Meaning program, an 8- week, text message- and audio-based intervention to promote physical activity in midlife adults. In Move with Meaning, participants will listen to weekly audio sessions and complete twice weekly text message sessions, in which they will set a weekly physical activity goal. The primary outcome is feasibility (measured by number of successful text message sessions sent). Secondary outcomes include acceptability and preliminary impact on physical activity, psychological health-, and physical health-related outcomes.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date February 1, 2025
Est. primary completion date February 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 64 Years
Eligibility Inclusion Criteria: - Midlife adults (aged 45-64 years at the time of enrollment) - Suboptimal physical activity (score < 6 on the Medical Outcomes Study Specific Adherence Scale physical activity item) - Access to a phone capable of receiving text messages and listening to audio files (i.e., a smartphone) Exclusion Criteria: - An unrelated condition limiting physical activity - Participation in any other programs focused on cardiac prevention or well-being - A cognitive disturbance precluding participation or informed consent - Current pregnancy - Inability to speak/write fluently in English

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Move with Meaning
Participants will engage in twice weekly text message sessions, will listen to a weekly audio session, and will work towards a physical activity goal each week, for a total of eight weeks.

Locations

Country Name City State
United States Massachusetts General Hospital Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Massachusetts General Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of text message sessions successfully delivered The automated platform will record rates of successful text message delivery. Weekly over 8 weeks
Secondary Proportion of audio sessions completed by participants We will record the number of sessions in which participants engaged (e.g., responded to a text message), out of a total of 8 sessions. Weekly over 8 weeks
Secondary Session utility Participants will rate the utility of each session, measured on a 10-point Likert scale. Higher scores indicate greater utility. Weekly over 8 weeks
Secondary Change in overall physical activity (in steps/day) Physical activity (steps) will be measured via an Actigraph accelerometer. We will use established accelerometer protocols to measure the mean number of steps taken per day at each time point. Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only)
Secondary Change in moderate to vigorous physical activity (MVPA; in mean minutes/day) MVPA (reported in mean minutes of MVPA/day) will be measured via an Actigraph accelerometer and recorded in mean minutes/day. Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only)
Secondary Change in sedentary time (in mean minutes/day) Sedentary time (mean minutes/day) will be measured via Actigraph accelerometer. Measured for 7 days at baseline (both groups), 8-weeks (both groups), and 16 weeks (wait-list control group only)
Secondary Change in self-reported physical activity (International Physical Activity Questionnaire [IPAQ]; in metabolic equivalent-minutes/week) This will be measured via the International Physical Activity Questionnaire (IPAQ) as a secondary measure of physical activity. Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)
Secondary Change in positive affect (Positive and Negative Affect Schedule [PANAS] positive affect items) Positive affect (our main psychological outcome given its links to health outcomes and sensitivity to change) will be assessed via the Positive and Negative Affect Schedule (PANAS) positive affect items. PANAS scores range from 10-50, with higher scores indicating higher levels of positive affect. Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)
Secondary Change in optimism (Life Orientation Test - Revised [LOT-R]) Optimism will be measured using the Life Orientation Test - Revised (LOT-R), a frequently used 6-item instrument that assesses dispositional optimism. LOT-R scores range from 0-24, with higher scores indicating higher levels of optimism. Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)
Secondary Change in depressive symptoms (depression subscale of the Hospital Anxiety and Depression Scale [HADS]). Depressive symptoms will be measured using the 7-item depression subscale of the Hospital Anxiety and Depression Scale (HADS). The depression subscale of the HADS ranges from 0-21, with higher scores indicating higher levels of depression. Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)
Secondary Change in anxiety (anxiety subscale of the Hospital Anxiety and Depression Scale [HADS]) Anxiety will be measured using the 7-item anxiety subscale of the Hospital Anxiety and Depression Scale (HADS). The anxiety subscale of the HADS ranges from 0-21, with higher scores indicating higher levels of anxiety. Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)
Secondary Change in exercise self-efficacy (Self-Efficacy for Exercise scale [SEE]) Exercise self-efficacy will be measured via the Self-Efficacy for Exercise (SEE) scale. SEE scores range from 0-90, with higher scores indicating higher levels of self-efficacy for exercise. Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)
Secondary Change in perceived social support (Multidimensional Scale of Perceived Social Support) Perceived social support will be measured by the Multidimensional Scale of Perceived Social Support (MSPSS). MSPSS scores range from 1-7, with higher scores indicating higher levels of perceived social support. Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)
Secondary Change in internal health locus of control (Multidimensional Health Locus of Control [MHLC] scale) Internal locus/sense of control will be measured using the Multidimensional Health Locus of Control (MHLC) scale. The internal locus of control score from the MHLC ranges from 6-36, with higher scores indicating greater internal locus of control. Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)
Secondary Change in positive affect during activity (Physical Activity Enjoyment Scale) Positive affect during activity will be measured using the Physical Activity Enjoyment Scale. Physical Activity Enjoyment Scale scores range from 18-126, with higher scores indicating higher levels of enjoyment during activity. Baseline (both groups), 8 weeks (both groups), 16 weeks (wait-list control group)
See also
  Status Clinical Trial Phase
Recruiting NCT05841667 - Impact of CES1 Genotype on Remimazolam
Active, not recruiting NCT04849052 - Text Messaging to Increase Activity in Midlife Phase 1
Completed NCT04745182 - A Tailored Program to Promote Well-being and Physical Activity in Mid-life Adults With Low Physical Activity N/A
Completed NCT05231564 - Hybrid Training and Middle Age N/A
Completed NCT05462977 - Rhythmically Entrained Exercise in Community-Dwelling Older Adults N/A
Completed NCT05163236 - Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening